Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Melanoma as a topic and MedlinePlus Genetics under related topics; no deletions were made.
    Difference
    0.2%
    Check dated 2026-04-11T10:29:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The Melanoma topic and the MedlinePlus Genetics link were removed from the Related Topics section. This reduces quick access to disease context and related educational resources.
    Difference
    0.2%
    Check dated 2026-04-04T05:25:10.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:36:23.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics. Updated site revision from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-06T18:15:43.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed the Melanoma label and the related topics: MedlinePlus Genetics from the page.
    Difference
    0.2%
    Check dated 2026-02-27T18:59:02.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Minor metadata updates: the page now shows a new revision label (v3.4.2) and adds the Melanoma keyword along with related topics such as MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T12:36:25.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.